Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1753–1776 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Pneumonia
Interventions: CP-70,429 and PF-03709270; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Circumcision
Interventions: AAP Documents, Parent Survival Guide; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 680 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Behcet Disease
Interventions: AIN457, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: Baltimore, Maryland • Arlington, Texas • Houston, Texas

Conditions: Spinal Stenosis Occipito-Atlanto-Axial, Spinal Disease, Spinal Stenosis Cervical, Spinal Stenosis Cervicothoracic Region, Spinal Instability
Interventions: Streamline Occipito-Cervico-Thoracic Spinal Fixation System; Device
Lead sponsor: RTI Surgical; Industry
Eligibility: Not listed
Enrollment: 60 participants
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Las Vegas, Nevada • Reno, Nevada

Conditions: Healthy Participants
Interventions: Hypoxic exposure; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Congestive Heart Failure
Interventions: self-paced instruction; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 95 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hemodynamic Measure, Cognitive Performance in Healthy Volunteers
Interventions: Maltodextrin (Placebo), Low dose theacrine, Medium dose theacrine, High dose theacrine; Dietary Supplement
Lead sponsor: Titch Madzima; Other
Eligibility: 18 Years to 40 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Elon, North Carolina

Conditions: Type 2 Diabetes Mellitus
Interventions: Aliskiren, Irbesartan, Captopril; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia, Depression, Suicidal Ideation
Interventions: Zolpidem-CR, Placebo; Drug
Lead sponsor: Augusta University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 4
States / cities: Augusta, Georgia • Durham, North Carolina • Wake Forest, North Carolina + 1 more

Conditions: AML and High Risk MDS
Interventions: LGH447, LGH447 + midostaurin; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Ultrasound Therapy; Complications
Interventions: Therapeutic Ultrasound; Device
Lead sponsor: North Dakota State University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Lymphangioleiomyomatosis
Interventions: Letrozole, Placebo; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 9
States / cities: Stanford, California • Jacksonville, Florida • Miami, Florida + 6 more

Conditions: Healthy
Interventions: DormoTech Vlab SpO2 sensor; Device
Lead sponsor: Dormotech Medical; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Dex-Methylphenidate hydrochloride Extended Release (Focalin® XR), Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 8
States / cities: Little Rock, Arkansas • Bradenton, Florida • South Miami, Florida + 4 more

Conditions: Diabetes Mellitus, Type 2
Interventions: linagliptine 5 mg, linagliptine 5 mg and pioglitazone 30 mg; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 82 Years
Enrollment: 2,122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 13
States / cities: Chula Vista, California • Spring Valley, California • Walnut Creek, California + 10 more

Conditions: Loneliness, Opioid Use
Interventions: Cognitive Behavior Therapy (CBT), Social Navigation Group, Controlled Group; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Osteoporosis
Interventions: Not listed
Lead sponsor: Artann Laboratories; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Urinary Incontinence
Interventions: Patient Education, Nurse Navigation, ChatBot; Other
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Anaemia
Interventions: GSK1278863, Placebo; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 46
States / cities: Azusa, California • Bakersfield, California • Chino, California + 38 more

Conditions: Blood Glucose, Blood Insulin
Interventions: Acute beverage (water) consumption, Acute beverage (Black Coffee) consumption, Acute beverage (Orange Juice) consumption, Acute beverage (Whole Milk) consumption, Acute beverage (2% Milk) consumption, Acute beverage (Skim Milk) consumption; Other
Lead sponsor: Purdue University; Other
Eligibility: 35 Years to 65 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Cancer
Interventions: Minimally invasive hemodynamic monitoring; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Respiratory Distress Syndrome in Premature Infants, Very Low Birth Weight Baby
Interventions: iNO, Nitrogen; Drug · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Minute to 2 Minutes
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma

Conditions: HIV-1-infection
Interventions: TMB-365; Biological
Lead sponsor: TaiMed Biologics Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 5
States / cities: San Francisco, California • Ft. Pierce, Florida • Orlando, Florida + 2 more

Conditions: Fertility
Interventions: Self administration; Procedure
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Fort Myers, Florida • Tampa, Florida

Search by objective public record fields.

A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function

Parents' Knowledge and Perception of Benefits and Risks Regarding Neonatal Circumcision

Phase III Study in Refractory Behcet's Disease

Streamline Occipito-Cervico-Thoracic System Post-Market Clinical Follow-up

Sex Differences in Reflex Responses to Intermittent Hypoxia

Developing and Assessing Competencies for Caregivers and Patients With Ventricular Assist Devices

Assessing the Impact of High Theacrine Doses on Hemodynamic Measures

A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus

Reducing Suicidal Ideation Through Insomnia Treatment

A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound

Letrozole for Lymphangioleiomyomatosis

The Accuracy of the Dormotech VLAB During Stable Hypoxia Plateaus

Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.

Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM

Decreasing Loneliness to Optimize Pain Care

Bone UltraSonic Scanner (BUSS) Clinical Optimization Study

Improving Care for Women With Urinary Incontinence (EMPOWER)

4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis

Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overwt/Obese Adults

Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery

Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation

Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants

Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate